LINCOLN.NS
Price:
$480.9
Market Cap:
$9.63B
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuret...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-12-17
Stock Exchange
NSE
Ticker
LINCOLN.NS
According to Lincoln Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current ROE is 11.86%. This represents a change of 299.16% compared to the average of 2.97% of the last 4 quarters.
The mean historical ROE of Lincoln Pharmaceuticals Limited over the last ten years is 15.70%. The current 11.86% ROE has changed -24.48% with respect to the historical average. Over the past ten years (40 quarters), LINCOLN.NS's ROE was at its highest in in the June 2016 quarter at 7.81%. The ROE was at its lowest in in the March 2017 quarter at 0.66%.
Average
15.70%
Median
15.88%
Minimum
12.26%
Maximum
18.08%
Discovering the peaks and valleys of Lincoln Pharmaceuticals Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 25.63%
Maximum Annual ROE = 18.08%
Minimum Annual Increase = -22.10%
Minimum Annual ROE = 12.26%
| Year | ROE | Change |
|---|---|---|
| 2025 | 12.26% | -22.10% |
| 2024 | 15.74% | 8.48% |
| 2023 | 14.51% | -9.45% |
| 2022 | 16.02% | -5.70% |
| 2021 | 16.99% | 3.41% |
| 2020 | 16.43% | -9.15% |
| 2019 | 18.08% | 17.12% |
| 2018 | 15.44% | 5.63% |
| 2017 | 14.62% | -13.72% |
| 2016 | 16.94% | 25.63% |
The current ROE of Lincoln Pharmaceuticals Limited (LINCOLN.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
14.17%
5-year avg
15.10%
10-year avg
15.70%
Lincoln Pharmaceuticals Limited’s ROE is less than Wanbury Limited (75.83%), less than Wanbury Limited (75.83%), greater than Themis Medicare Limited (-6.76%), greater than Themis Medicare Limited (-6.76%), less than Sakar Healthcare Limited (6.82%), less than Venus Remedies Limited (12.73%), less than Venus Remedies Limited (12.73%), greater than Max India Limited (-36.92%), less than Ind-Swift Laboratories Limited (22.80%), less than Ind-Swift Laboratories Limited (22.80%),
| Company | ROE | Market cap |
|---|---|---|
| 75.83% | $7.55B | |
| 75.83% | $7.52B | |
| -6.76% | $9.41B | |
| -6.76% | $9.41B | |
| 6.82% | $9.26B | |
| 12.73% | $10.23B | |
| 12.73% | $10.36B | |
| -36.92% | $9.88B | |
| 22.80% | $6.85B | |
| 22.80% | $6.87B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lincoln Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lincoln Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Lincoln Pharmaceuticals Limited's ROE?
How is the ROE calculated for Lincoln Pharmaceuticals Limited (LINCOLN.NS)?
What is the highest ROE for Lincoln Pharmaceuticals Limited (LINCOLN.NS)?
What is the 3-year average ROE for Lincoln Pharmaceuticals Limited (LINCOLN.NS)?
What is the 5-year average ROE for Lincoln Pharmaceuticals Limited (LINCOLN.NS)?
How does the current ROE for Lincoln Pharmaceuticals Limited (LINCOLN.NS) compare to its historical average?